SP7 and type 2 diabetes mellitus: This result makes a striking parallel to our findings in type 2 diabetes patients with CC, who displayed elevated MCC levels and suppression of SIRT7, along with activation of the pro-calcific program (RUNX2 and OSX/SP7) within myeloid cells.